Patent details

EP2650007 Title: Use of cell-permeable peptide inhibitors of the JNK signal transduction pathway for the treatment of various autoimmune diseases.

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
EP2650007
WO Application Number:
Type:
European Patent Granted for NL
Status:
Lapsed by non-payment of annual fee Art. 62 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP13002792.3
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Cyprus (CY)
Publications:

Dates

Filing date:
02/06/2009
Grant date:
20/05/2015
EP Publication Date:
20/05/2015
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
01/07/2017
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
20/05/2015
EP B1 Publication Date:
20/05/2015
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
08/07/2015
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
01/06/2029
Lapsed By Expiration Date:
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:

Applicant/holder

From:
20/05/2015
 
 

 

Name:
Xigen Inflammation Ltd.
Address:
Arch. Makariou III 195 Neocleous House, 3030 LIMASSOL, Cyprus (CY)

Domicile Holder

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
20/05/2015
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Inventor

Name:
Bonny, Christophe
Address:
1580 AVENCHES, Switzerland (CH)

Priority

Priority Patent Number:
PCT/EP2008/004341
Priority Date:
30/05/2008
Priority Country:
World Intellectual Property Office (WIPO) (WO)

Classification

Main IPC Class:
A61K 38/01;
IPC or IDT classification:
A61K 38/03; A61K 38/04; A61P 9/00; A61P 11/00; A61P 17/00; A61P 25/00; A61P 31/12; A61P 37/00;

Publication

Bulletin

1

Bulletin Heading:
VRV
Journal edition number:
07/18
Publication date:
07/02/2018
Description:
Lapse or annulment

2

Bulletin Heading:
EP3
Journal edition number:
2015/31
Publication date:
29/07/2015
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995

3

Bulletin Heading:
EP2
Journal edition number:
2015/22
Publication date:
27/05/2015
Description:
European patents granted for the Netherlands

European Patent Bulletin

Issue number:
201521
Publication date:
20/05/2015
Description:
Grant (B1)

Annual Fee

Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
21/06/2016
Last Annual Fee Paid Number:
8
Last Annual Fee Paid Amount:
280 Euro
Payer:
PAVIS GmbH
Filing date Document type Document Description Number of pages File Type
20/07/2015 Outgoing Correspondence Outgoing Letter 1 PDF /2/9/7/2/0/0513002792/docs/ep13002792.3_2_outgoingcorrespondence20150720.pdf
08/07/2015 Outgoing Correspondence Outgoing Letter 1 PDF /2/9/7/2/0/0513002792/docs/ep13002792.3_0_outgoingcorrespondence20150708.pdf
08/07/2015 Claims Translated claims 2 PDF /2/9/7/2/0/0513002792/docs/ep13002792.3_3_claims20150708.pdf
08/07/2015 Incoming Correspondence Paper Accompanying letter incoming document 2 PDF /2/9/7/2/0/0513002792/docs/ep13002792.3_4_incomingcorrespondencepaper20150708.pdf
05/06/2015 Incoming Correspondence Paper Correspondence address details 1 PDF /2/9/7/2/0/0513002792/docs/ep13002792.3_1_incomingcorrespondencepaper20150605.pdf